Skip to main content
. 2021 Feb 25;13:640677. doi: 10.3389/fnagi.2021.640677

Figure 8.

Figure 8

TW1 passive immunotherapy reduces biochemical tau pathology in the hTau/PS1 mice model. Densitometric analysis of the blots from the soluble fraction indicates that an equal amount of tau protein was used in treated vs. control animals (A,D). PHF-1 staining shows a decrease of pathological tau in treated animals compared to the controls (*p = 0.03; two-tailed t-test; B). A significant reduction was also observed in the ratio of PHF1/Tubilin (***p = 0.0006; two-tailed t-test; C). With CP13 antibody immunoblotting a reduction of tau pathology in treated animals vs. controls is observed (***p = 0.0007; two-tailed t-test; E). A comparable effect was observed in the ratio CP13/Tubulin (**p = 0.0014; two-tailed t-test; F).